Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 285, Issue 2 54-2, 2003, Pages

  Hayashida, Ken ichiro ^a   Takeuchi, Takashi ^a   Shimizu, Hirohiko ^b   Ando, Kunio ^b   Harada, Etsumori ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Nuclear Receptor Ligand Co Ltd   (Japan)

Author keywords

D Phe Cys Tyr D Trp Orn Thr NH2; Formalin test; NG nitro L arginine methyl ester; Tail flick test; Tolerance

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; LACTOFERRIN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE DERIVATIVE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BODY FLUID; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HORMONE ACTION; MALE; MILK; NEUTROPHIL; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SPINAL CORD; TAIL FLICK TEST;

EID: 0042092538     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00760.2002     Document Type: Article

References (43)

1. Brock JH. The physiology of lactoferrin. Biochem Cell Biol 80: 1-6, 2002.
2. Cousins MJ and Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology 61: 276-310, 1984.
3. 2+ channels induced by nitric oxide in human neuroblastoma IMR32 cells. J Neurosci 22: 7485-7492, 2002.
4. Duarte ID and Ferreira SH. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 221: 171-174, 1992.
5. Dun NJ, Dun SL, Wu SY, Forstermann U, Schmidt HH, and Tseng LF. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience 54: 845-857, 1993.
6. Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y, et al. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 92: 9603-9607, 1995.
7. Fillebeen C, Dehouck B, Benaissa M, Dhennin-Duthille I, Cecchelli R, and Pierce A. Tumor necrosis factor-α increases lactoferrin transcytosis through the blood-brain barrier. J Neurochem 73: 2491-2500, 1999.
8. Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaissa M, Spik G, Cecchelli R, and Pierce A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 274: 7011-7017, 1999.
9. Fillebeen C, Ruchoux MM, Mitchell V, Vincent S, Benaissa M, and Pierce A. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor-α or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 96: 103-113, 2001.
10. Harada E, Sugiyama A, Takeuchi T, Sitizyo K, Syuto B, Yajima T, and Kuwata T. Characteristic transfer of colostral components into cerebrospinal fluid via serum in neonatal pigs. Biol Neonate 76: 33-43, 1999.
11. Hayashida K, Takeuchi T, Shimizu H, Ando K, and Harada E. Novel function of bovine milk-derived lactoferrin on antinociception mediated by μ-opioid receptor in the rat spinal cord. Brain Res 965: 239-245, 2003.
12. Ibuki T, Dunbar SA, and Yaksh TL. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain 70: 125-132, 1997.
13. Kawabata A, Fukuzumi Y, Fukushima Y, and Takagi H. Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems. Eur J Pharmacol 218: 153-158, 1992.
14. Kawabata A, Nishimura Y, and Takagi H. L-Leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia. Br J Pharmacol 107: 1096-1101, 1992.
15. Kawabata A, Umeda N, and Takagi H. L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br J Pharmacol 109: 73-79, 1993.
16. Kolesnikov YA, Pan YX, Babey AM, Jain S, Wilson R, and Pasternak GW. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci USA 94: 8220-8225, 1997.
17. Lauretti GR, Perez MV, Reis MP, and Pereira NL. Double-blind evaluation of transdermal nitroglycerine as adjuvant to oral morphine for cancer pain management. J Clin Anesth 14: 83-86, 2002.
18. Lebrun P, Manil J, and Colin F. Formalin-induced central sensitization in the rat: somatosensory evoked potential data. Neurosci Lett 283: 113-116, 2000.
19. Levay PF and Viljoen M. Lactoferrin: a general review. Haematologica 80: 252-267, 1995.
20. Leveugle B, Faucheux BA, Bouras C, Nillesse N, Spik G, Hirsch EC, Agid Y, and Hof PR. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol (Berl) 91: 566-572, 1996.
21. Machelska H, Labuz D, Przewlocki R, and Przewlocka B. Inhibition of nitric oxide synthase enhances antinociception mediated by μ-, δ- and κ-opioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther 282: 977-984, 1997.
22. Maffei FA, Heine RP, Whalen MJ, Mortimer LF, and Carcillo JA. Levels of antimicrobial molecules defensin and lactoferrin are elevated in the cerebrospinal fluid of children with meningitis. Pediatrics 103: 987-992, 1999.
23. Malmberg AB and Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 263: 136-146, 1992.
24. Masson PL and Heremans JF. Lactoferrin in milk from different species. Comp Biochem Physiol B Biochem Mol Biol 39: 119-129, 1971.
25. Masson PL, Heremans JF, and Dive C. An iron-binding protein common to many external secretions. Clin Chim Acta 14: 735-739, 1966.
26. Meller ST and Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127-136, 1993.
27. Millan MJ. Descending control of pain. Prog Neurobiol 66: 355-474, 2002.
28. Milne B, Cervenko F, Jhamandas K, Loomis C, and Sutak M. Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat. Pain 22: 165-172, 1985.
29. Ness TJ and Follett KA. The development of tolerance to intrathecal morphine in rat models of visceral and cutaneous pain. Neurosci Lett 248: 33-36, 1998.
30. Owen JA, Tasker RA, and Nakatsu K. A simple, less stressful rat restrainer. Experientia 40: 306-308, 1984.
31. Saito S, Kidd GJ, Trapp BD, Dawson TM, Bredt DS, Wilson DA, Traystman RJ, Snyder SH, and Hanley DF. Rat spinal cord neurons contain nitric oxide synthase. Neuroscience 59: 447-456, 1994.
32. Sewell RD and Spencer PS. Antinociceptive activity of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacology 15: 683-688, 1976.
33. Sorimachi K, Akimoto K, Hattori Y, Ieiri T, and Niwa A. Activation of macrophages by lactoferrin: secretion of TNF-α, IL-8 and NO. Biochem Mol Biol Int 43: 79-87, 1997.
34. Stein C, Machelska H, Binder W, and Schafer M. Peripheral opioid analgesia. Curr Opin Pharmacol 1: 62-65, 2001.
35. Talukder MJ, Takeuchi T, and Harada E. Transport of colostral macromolecules into the cerebrospinal fluid via plasma in newborn calves. J Dairy Sci 85: 514-524, 2002.
36. Teng CT. Lactoferrin gene expression and regulation: an overview. Biochem Cell Biol 80: 7-16, 2002.
37. Teschemacher H and Koch G. Opioids in the milk. Endocr Regul 25: 147-150, 1991.
38. Wang YX, Gao D, Pettus M, Phillips C, and Bowersox SS. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats. Pain 84: 271-281, 2000.
39. Weizman R, Pankova IA, Schreiber S, and Pick CG. Flunarizine analgesia is mediated by μ-opioid receptors. Physiol Behav 62: 1193-1195, 1997.
40. Wheeler-Aceto H, Porreca F, and Cowan A. The rat paw formalin test: comparison of noxious agents. Pain 40: 229-238, 1990.
41. Xu JY, Pieper GM, and Tseng LF. Activation of a NO-cyclic GMP system by NO donors potentiates β-endorphin-induced antinociception in the mouse. Pain 63: 377-383, 1995.
42. Yaksh TL and Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17: 1031-1036, 1976.
43. ω-nitro-L-arginine methyl ester on thermal nociceptive tests in the rats. Can J Anaesth 43: 975-981, 1996.